Genus plc (LON:GNS – Get Free Report) insider Celia Baxter purchased 1,728 shares of the stock in a transaction on Friday, February 27th. The stock was acquired at an average cost of GBX 2,893 per share, for a total transaction of £49,991.04.
Genus Stock Up 2.6%
Shares of LON GNS opened at GBX 2,915 on Friday. Genus plc has a 12 month low of GBX 1,548 and a 12 month high of GBX 3,220. The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.12. The firm has a market capitalization of £1.94 billion, a price-to-earnings ratio of 100.87, a PEG ratio of 2.87 and a beta of 0.37. The business has a 50-day moving average of GBX 2,845.83 and a 200-day moving average of GBX 2,649.56.
Genus (LON:GNS – Get Free Report) last announced its earnings results on Thursday, February 26th. The company reported GBX 60.80 earnings per share for the quarter. Genus had a net margin of 1.18% and a return on equity of 1.41%. Sell-side analysts expect that Genus plc will post 70.9644323 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Check Out Our Latest Report on GNS
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Featured Articles
- Five stocks we like better than Genus
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
